Arcutis Biotherapeutics

Arcutis (Nasdaq: ARQT) was founded in 2016 to address significant unmet needs in medical dermatology. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing best-in-class products.



Post IPO Debt




Org chart

Frank Watanabe
President and CEO
Patrick Burnett
Chief Medical Officer
David Osborne
Chief Technical Officer
Kenneth Lock
Chief Commercial Officer
Matthew Moore
Chief Business Officer
Raj Madan
Chief Digital & Technology Officer
Courtney Barton
Vice President & Chief Compliance Officer
Don Plummer
Chief of Staff & Head, ESG
Keith Klein
General Counsel
Mas Matsuda
General Counsel
Patricia Turney
Senior Vice President, Operations
Scott Burrows
Vice President, Finance
Bethany Dudek
Vice President, Quality
Ayisha Jeter
Interim Chief Commercial Officer
Kimberly Lathroum
Vice President, Marketing
Charlotte Merritt
Vice President, Regulatory Affairs
Gregory Sukay
Vice President, Manufacturing & Process Technologies
Bruce Binkowitz
Vice President, Biometrics
Jessica Robison
Vice President, Finance & Corporate Controller
Todd Tucker
Vice President, Human Resources
Scott Snyder
Vice President, Product Safety & Pharmacovigilance
David Chu
VP, Clinical Development
Don Plummer
Executive Director, Chief of Staff & Head, ESG
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.